StockWatch
·

SMS Lifesciences India Ltd Q4 FY25 Results

HALEOSLABSQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue89.115.3%
Total Income91.458.0%
Expenditure87.5212.6%
PBT3.9343.2%
Net Profit3.4828.2%
OPM8.33%7.19pp
NPM3.81%1.92pp
EPS9.8345.6%
View full financials

Informational and educational content only. Not investment advice.